Optimizerx Corporation (OPRX)
NASDAQ:OPRX
Want to see OPRX full AI Analyst Report?
Total Valuation
OptimizeRx has a market cap or net worth of $93.26M. The enterprise value is $96.25M.
Market Cap$93.26M
Enterprise Value$96.25M
Share Statistics
OptimizeRx has 18,765,076 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,765,076
Owned by Insiders6.42%
Owned by Institutions30.89%
Financial Efficiency
OptimizeRx’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 5.56%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)5.56%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee854.91K
Profits Per Employee40.09K
Employee Count128
Asset Turnover0.62
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of OptimizeRx is ―. OptimizeRx’s PEG ratio is -0.35.
PE Ratio―
PS Ratio2.08
PB Ratio1.77
Price to Fair Value1.77
Price to FCF12.19
Price to Operating Cash Flow6.44
PEG Ratio-0.35
Income Statement
In the last 12 months, OptimizeRx had revenue of 109.43M and earned 5.13M in profits. Earnings per share was 0.28.
Revenue109.43M
Gross Profit69.27M
Operating Income12.06M
Pretax Income6.95M
Net Income5.13M
EBITDA16.39M
Earnings Per Share (EPS)0.28
Cash Flow
In the last 12 months, operating cash flow was 14.38M and capital expenditures -52.00K, giving a free cash flow of 14.33M billion.
Operating Cash Flow14.38M
Free Cash Flow14.33M
Free Cash Flow per Share0.76
Dividends & Yields
OptimizeRx pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.89
52-Week Price Change-59.14%
50-Day Moving Average6.29
200-Day Moving Average12.60
Relative Strength Index (RSI)33.23
Average Volume (3m)515.91K
Important Dates
OptimizeRx upcoming earnings date is Aug 6, 2026, TBA (Confirmed).
Last Earnings DateMay 12, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
OptimizeRx as a current ratio of 3.04, with Debt / Equity ratio of 18.30%
Current Ratio3.04
Quick Ratio3.04
Debt to Market Cap0.11
Net Debt to EBITDA0.17
Interest Coverage Ratio2.28
Taxes
In the past 12 months, OptimizeRx has paid 1.82M in taxes.
Income Tax1.82M
Effective Tax Rate0.26
Enterprise Valuation
OptimizeRx EV to EBITDA ratio is 14.05, with an EV/FCF ratio of 12.34.
EV to Sales2.10
EV to EBITDA14.05
EV to Free Cash Flow12.34
EV to Operating Cash Flow12.30
Balance Sheet
OptimizeRx has $20.17M in cash and marketable securities with $23.72M in debt, giving a net cash position of -$3.55M billion.
Cash & Marketable Securities$20.17M
Total Debt$23.72M
Net Cash-$3.55M
Net Cash Per Share-$0.19
Tangible Book Value Per Share$0.90
Margins
Gross margin is 69.05%, with operating margin of 11.02%, and net profit margin of 4.69%.
Gross Margin69.05%
Operating Margin11.02%
Pretax Margin6.35%
Net Profit Margin4.69%
EBITDA Margin14.98%
EBIT Margin11.02%
Analyst Forecast
The average price target for OptimizeRx is $12.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$12.00
Price Target Upside67.36% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast13.75%
EPS Growth Forecast―